Novartis (NVS) ROA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | 18.2% | 5.92% | 14.9% | 11.7% | 12.2% | 11.4% | ||
| Changes by years, y/y, % | +12pp | -12pp | +9pp | -3pp | +0pp | +14.8% | |||
Novartis. ROA, %
Novartis. ROA, changes, pp
Novartis (NVS) ROA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROA, % | ? | 12.9% | 13.1% | 13.4% | 12.1% | 11.4% | 11.4% | |
| Changes by years, y/y, % | -3pp | -4pp | -4pp | +0pp | -1pp | |||
| Changes by quarters, q/q, % | +1pp | +0pp | +0pp | -1pp | -1pp | |||